James Love

A phase II double-blind study to investigate efficacy and safety of two doses of the triple angiokinase inhibitor BIBF 1120 in patients with relapsed advanced non-small-cell lung cancer

Martin Reck, R. Kaiser, C. Eschbach et al. · Annals of Oncology · 2011 · 149 citations · Full text

Medicine, Oncology, Pharmacology +9

A pandemic treaty for equitable global access to medical countermeasures: seven recommendations for sharing intellectual property, know-how and technology

Katrina Perehudoff, Ellen ‘t Hoen, Kaitlin Mara et al. · BMJ Global Health · 2022 · 37 citations · Full text

Law, Health Policy, Intellectual Property Law +17

Labeling Changes and Costs for Clinical Trials Performed Under the US Food and Drug Administration Pediatric Exclusivity Extension, 2007 to 2012

Michael S. Sinha, Mehdi Najafzadeh, Elizabeth K. Rajasingh et al. · JAMA Internal Medicine · 2018 · 27 citations · Full text

Pharmacy, Pediatrics, Pharmaceutical Policy +17

Diagnosis and Management of Lemmel Syndrome: An Unusual Presentation and Literature Review

James Love, Meredith Yellen, Constantine Melitas et al. · Case Reports in Gastroenterology · 2022 · 25 citations · Full text

Medicine, Internal Medicine, Surgery +17

A double blind phase II study of BIBF 1,120 in patients suffering from relapsed advanced non-small cell lung cancer (NSCLC)

Joachim von Pawel, R. Kaiser, C. Eschbach et al. · Journal of Clinical Oncology · 2007 · 19 citations

Medicine, Oncology, Pharmacology +16